Meera Mohan

49PUBLICATIONS
96CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cell physiologyGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (49)

|Jun 09, 2026
Sustained disease remission after a limited duration of bispecific antibody therapy in patients with multiple myeloma.

|May 01, 2026
The Association of Age and Frailty With Adverse Events for Bortezomib and Carfilzomib: A Population-Based Analysis.

|Apr 14, 2026
Safety and efficacy of ciltacabtagene autoleucel for relapsed/refractory multiple myeloma: a CIBMTR study.

Doris K Hansen, Danai Dima, Hira Mian

|Mar 25, 2026
Final clinical data of a phase 1 dose-escalation study of WVT078, a BCMA×CD3 bispecific antibody, alone and in combination with γ-secretase inhibitor WHG626 in patients with relapsed and/or refractory multiple myeloma.

Fredrik Schjesvold, Andrew Spencer, Yael C Cohen

|Mar 09, 2026
Changes in patient-reported distress and symptom burden during talquetamab therapy in multiple myeloma.

Elizabeth Aughey, Noel Estrada-Merly, Othman Salim Akhtar

|Feb 24, 2026
Plasma cell leukemia: genomic features and their potential relevance for exploring clinical actionability.

Meera Mohan, Natalie Danziger, Othman Salim Akhtar

Pageof 9

Frequent Collaborators

19 joint publications

Binod Dhakal

17 joint publications

Anita D'Souza

17 joint publications

Carolina Schinke

11 joint publications

Aniko Szabo